Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
5m
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the European Union based on earlier trial readouts. Outside of Japan and the UAE, ...
43m
Sanofi, Regeneron's Dupixent SBLA Accepted For FDA Review To Treat Chronic Spontaneous Urticaria
French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Tapped for health secretary
Florida sues FEMA officials
FBI offering up to $25K
Named grand marshal
Vonn ending her retirement
To close hundreds of stores
E. coli cases climb to 104
OH trans bathroom bill
Bohannan requests recount
IN gender-affirming care ban
Ben & Jerry's sues Unilever
To replace Kotb on 'Today'
CDC: OD deaths down
Faces up to $165M penalty
Military suicides increased
Remains ID'd after 82 years
House GOP conference chair
Largest coral ever recorded
China hacked telecom firms
To run Interior Department
Global increase in diabetes
DOJ report on Fulton jail
Israeli airstrikes hit Syria
Seeks pause in docs appeal
Israel accused of war crimes
Judge blocks name change
Notre Dame set to reopen
Tropical Storm Sara forms
Weekly jobless claims fall
Bed rails recalled
The Onion buys Infowars
EU fines Meta
Feedback